Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America IVD In Cardiology And Neurology Market, by Product Type
1.4.2 North America IVD In Cardiology And Neurology Market, by End Use
1.4.3 North America IVD In Cardiology And Neurology Market, by Technology
1.4.4 North America IVD In Cardiology And Neurology Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. North America IVD In Cardiology And Neurology Market by Product Type
4.1 North America Reagents & Consumables Market by Country
4.2 North America Instruments Market by Country
4.3 North America Software & Services Market by Country
Chapter 5. North America IVD In Cardiology And Neurology Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Clinical Laboratories Market by Country
5.3 North America Others Market by Country
Chapter 6. North America IVD In Cardiology And Neurology Market by Technology
6.1 North America Immunoassays Market by Country
6.2 North America Molecular Diagnostics Market by Country
6.3 North America Hematology Market by Country
6.4 North America Others Market by Country
Chapter 7. North America IVD In Cardiology And Neurology Market by Country
7.1 US IVD In Cardiology And Neurology Market
7.1.1 US IVD In Cardiology And Neurology Market by Product Type
7.1.2 US IVD In Cardiology And Neurology Market by End-use
7.1.3 US IVD In Cardiology And Neurology Market by Technology
7.2 Canada IVD In Cardiology And Neurology Market
7.2.1 Canada IVD In Cardiology And Neurology Market by Product Type
7.2.2 Canada IVD In Cardiology And Neurology Market by End-use
7.2.3 Canada IVD In Cardiology And Neurology Market by Technology
7.3 Mexico IVD In Cardiology And Neurology Market
7.3.1 Mexico IVD In Cardiology And Neurology Market by Product Type
7.3.2 Mexico IVD In Cardiology And Neurology Market by End-use
7.3.3 Mexico IVD In Cardiology And Neurology Market by Technology
7.4 Rest of North America IVD In Cardiology And Neurology Market
7.4.1 Rest of North America IVD In Cardiology And Neurology Market by Product Type
7.4.2 Rest of North America IVD In Cardiology And Neurology Market by End-use
7.4.3 Rest of North America IVD In Cardiology And Neurology Market by Technology
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.6 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Sysmex Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Siemens Healthineers AG (Siemens AG)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.6 SWOT Analysis
8.5 Quest Diagnostics Incorporated
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Acquisition and Mergers:
8.5.5 SWOT Analysis
8.6 Abbott Laboratories
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 SWOT Analysis
8.8 Danaher Corporation (Beckman Coulter)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 SWOT Analysis
8.9 Becton, Dickinson, and Company
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 SWOT Analysis
8.10. Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 